Detalles de la búsqueda
1.
Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.
Circulation
; 149(10): 747-759, 2024 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37883784
2.
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Am Heart J
; 267: 1-11, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37758044
3.
Managing Hypertension in Older Adults.
Curr Hypertens Rep
; 26(4): 157-167, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38150080
4.
General versus central adiposity as risk factors for cardiovascular-related outcomes in a high-risk population with type 2 diabetes: a post hoc analysis of the REWIND trial.
Cardiovasc Diabetol
; 22(1): 52, 2023 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899386
5.
Endovascular Ultrasound Renal Denervation to Treat Hypertension: The RADIANCE II Randomized Clinical Trial.
JAMA
; 329(8): 651-661, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36853250
6.
Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.
Lancet
; 397(10293): 2476-2486, 2021 06 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34010611
7.
A novel kidney disease index reflecting both the albumin-to-creatinine ratio and estimated glomerular filtration rate, predicted cardiovascular and kidney outcomes in type 2 diabetes.
Cardiovasc Diabetol
; 21(1): 158, 2022 08 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35996147
8.
Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial.
Diabetes Obes Metab
; 24(4): 704-712, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984808
9.
Similar cardiovascular outcomes in patients with diabetes and established or high risk for coronary vascular disease treated with dulaglutide with and without baseline metformin.
Eur Heart J
; 42(26): 2565-2573, 2021 07 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33197271
10.
Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association.
Circulation
; 142(4): e42-e63, 2020 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32567342
11.
How We Got Where We Are in Blood Pressure Targets.
Curr Hypertens Rep
; 23(6): 33, 2021 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34110518
12.
Six-Month Results of Treatment-Blinded Medication Titration for Hypertension Control After Randomization to Endovascular Ultrasound Renal Denervation or a Sham Procedure in the RADIANCE-HTN SOLO Trial.
Circulation
; 139(22): 2542-2553, 2019 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-30880441
13.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Lancet
; 394(10193): 121-130, 2019 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189511
14.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Lancet
; 394(10193): 131-138, 2019 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31189509
15.
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Cardiovasc Diabetol
; 19(1): 199, 2020 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239067
16.
Hypertension in the elderly: recent developments and insights.
Curr Opin Cardiol
; 35(4): 351-356, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32452921
17.
Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial.
Lancet
; 391(10137): 2335-2345, 2018 06 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29803590
18.
A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs.
Am Heart J
; 195: 115-129, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29224639
19.
Influence of metabolic syndrome and race on the relationship between intensive blood pressure control and cardiovascular outcomes in the SPRINT cohort.
Diabetes Obes Metab
; 20(3): 629-637, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29024310
20.
Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide.
Diabetes Obes Metab
; 20(1): 42-49, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573765